Oliver Dorigo, Ph.D.
Affiliations: | 2003 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, Cell BiologyGoogle:
"Oliver Dorigo"Parents
Sign in to add mentor| Arnold J. Berk | grad student | 2003 | UCLA | |
| (Development of a helper dependent adenovirus: Epstein -Barr virus hybrid system for stable transformation of mammalian cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dorigo O, Fiset S, MacDonald LD, et al. (2020) DPX-Survivac, a novel T-cell immunotherapy, to induce robust T-cell responses in advanced ovarian cancer. Journal of Clinical Oncology. 38: 6-6 |
| Dorigo O, MacDonald LD, Schindler J, et al. (2020) Infiltration of tumor by T cells following treatment with DPX-Survivac and intermittent low dose cyclophosphamide (CPA) leads to clinical responses in advanced recurrent ovarian cancer (OvCa). Journal of Clinical Oncology. 38: 6075-6075 |
| Barkal AA, Brewer RE, Markovic M, et al. (2019) CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature |
| Möckl L, Pedram K, Roy AR, et al. (2019) Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx. Developmental Cell |
| Malaker SA, Pedram K, Ferracane MJ, et al. (2019) The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proceedings of the National Academy of Sciences of the United States of America |
| Natarajan S, Foreman KM, Soriano MI, et al. (2019) Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis. Cancer Research |
| Tanyi JL, Dorigo O, Oza AM, et al. (2019) DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE1 trial): T cell responses and tumor infiltration correlate with tumor regression. Journal of Clinical Oncology. 37: 5576-5576 |
| Natarajan S, Foreman K, Soriano M, et al. (2019) Abstract TMIM-081: THE HYPOXIC TUMOR-MESOTHELIAL NICHE PROMOTES OVARIAN CANCER METASTASIS THROUGH COLLAGEN REMODELING Clinical Cancer Research. 25 |
| Krishnan V, Tallapragada S, Schaar B, et al. (2019) Abstract TMIM-076: OMENTAL MACROPHAGES REGULATE OVARIAN CANCER METASTATIC COLONIZATION THROUGH THE CCL6-CCR1 SIGNALING AXIS Clinical Cancer Research. 25 |
| Gill NK, Ly C, Nyberg KD, et al. (2018) A scalable filtration method for high throughput screening based on cell deformability. Lab On a Chip |